CRON Logo

Cronos Group Inc (CRON) Stock Forecast & Price Prediction

Live CRON Stock Price & Analysis

Home โ€บ Stocks โ€บ Canada | NASDAQ | Healthcare | Drug Manufacturers - Specialty & Generic

$1.97

-0.03 (-1.50%)

12 Month Price Forecast For CRON

$1.97
Current Price
$754.12M
Market Cap
5 Ratings
Buy 2
Hold 2
Sell 1
Wall St Analyst Ratings

Distance to CRON Price Forecasts

+8.2%
To High Target of $2.13
+4.1%
To Median Target of $2.05
+0.0%
To Low Target of $1.97

CRON Price Momentum

+2.1%
1 Week Change
-0.5%
1 Month Change
-10.5%
1 Year Change
-2.5%
Year-to-Date Change
-37.3%
From 52W High of $3.14
+7.7%
From 52W Low of $1.83

๐Ÿค” Considering Cronos Group (CRON)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 15, 2025 1:01 PM UTC

CRON Analyst Ratings & Price Targets

Based on our analysis of 8 Wall Street analysts, CRON has a neutral consensus with a median price target of $2.05 (ranging from $1.97 to $2.13). Currently trading at $1.97, the median forecast implies a 4.1% upside. This outlook is supported by 2 Buy, 2 Hold, and 1 Sell ratings.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

CRON Analyst Consensus

2
Buy
2
Hold
1
Sell

CRON Price Target Range

Low
$1.97
Average
$2.05
High
$2.13
Current: $1.97

Latest CRON Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for CRON.

Date Firm Analyst Rating Change Price Target
May 15, 2024 CIBC John Zamparo Outperformer Maintains $3.50
Apr 8, 2024 B of A Securities Lisa Lewandowski Underperform Maintains $2.50
Dec 28, 2023 B of A Securities Lisa Lewandowski Underperform Maintains $2.00
May 15, 2023 Barclays Gaurav Jain Equal-Weight Maintains $3.00
Nov 2, 2022 Bernstein Nadine Sarwat Market Perform Initiates $3.00
Sep 30, 2022 Barclays Gaurav Jain Equal-Weight Maintains $3.50
Mar 22, 2022 Barclays Gaurav Jain Equal-Weight Upgrade $0.00
Mar 7, 2022 Piper Sandler Michael Lavery Neutral Maintains $3.00
Feb 22, 2022 Canaccord Genuity Matt Bottomley Sell Maintains $4.25
Feb 22, 2022 Piper Sandler Michael Lavery Neutral Maintains $4.00
Jan 27, 2022 Jefferies Owen Bennett Hold Upgrade $3.24
Nov 18, 2021 Barclays Underweight Initiates $0.00
Apr 14, 2020 Piper Sandler Neutral Downgrade $0.00
Mar 31, 2020 Canaccord Genuity Sell Downgrade $0.00
Nov 13, 2019 Bank of America Buy Maintains $0.00
Nov 13, 2019 B of A Securities Buy Maintains $15.00
Oct 22, 2019 Piper Jaffray Overweight Maintains $0.00
Oct 22, 2019 Piper Sandler Overweight Maintains $12.00
Aug 13, 2019 Piper Sandler Overweight Initiates $0.00
Aug 13, 2019 Piper Jaffray Overweight Initiates $0.00

Stocks Similar to Cronos Group Inc

The following stocks are similar to Cronos Group based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Cronos Group Inc (CRON) Financial Data

Cronos Group Inc has a market capitalization of $754.12M with a P/E ratio of -10.4x. The company generates $111.23M in trailing twelve-month revenue with a -42.7% profit margin.

Revenue growth is +38.1% quarter-over-quarter, while maintaining an operating margin of -34.5% and return on equity of -4.4%.

Valuation Metrics

Market Cap $754.12M
Enterprise Value $-57,310,428
P/E Ratio -10.4x
PEG Ratio -49.3x
Price/Sales 6.8x

Growth & Margins

Revenue Growth (YoY) +38.1%
Gross Margin +10.5%
Operating Margin -34.5%
Net Margin -42.7%
EPS Growth +38.1%

Financial Health

Cash/Price Ratio +114.5%
Current Ratio 24.2x
Debt/Equity 0.2x
ROE -4.4%
ROA -3.1%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Cronos Group Inc logo

Cronos Group Inc (CRON) Company Overview

About Cronos Group Inc

What They Do

Cannabinoid company producing various cannabis products.

Business Model

Cronos Group Inc. operates by cultivating, producing, and marketing a diverse range of cannabis products. The company generates revenue through the sale of its products, which include dried flower, pre-rolls, oils, vaporizers, edibles, and tinctures, marketed under well-known brands such as Spinach, Lord Jones, and PEACE NATURALS.

Additional Information

Founded in 2012 and headquartered in Toronto, Canada, Cronos Group Inc. has expanded its operations internationally, including markets in Israel and Germany, positioning itself in the growing global cannabis industry.

Company Information

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

356

CEO

Mr. Michael Ryan Gorenstein J.D.

Country

Canada

IPO Year

2018

Cronos Group Inc (CRON) Latest News & Analysis

CRON stock latest news image
Quick Summary

Cannabis stocks are influenced by speculation regarding potential federal reforms related to marijuana legislation.

Why It Matters

Federal reforms can significantly impact cannabis stock valuations, influencing market sentiment and investment strategies based on regulatory changes and growth prospects.

Source: Market Watch
Market Sentiment: Positive
CRON stock latest news image
Quick Summary

Investors in marijuana stocks face uncertainty due to the lack of federal reform in the U.S., despite state-level legalization creating legal markets for cannabis production.

Why It Matters

Uncertainty in federal cannabis reform affects investor confidence in marijuana stocks, as state-level legalization does not guarantee stability for legal operators.

Source: MarijuanaStocks
Market Sentiment: Neutral
CRON stock latest news image
Quick Summary

The U.S. cannabis market, exceeding $25 billion in 2021, is projected to reach $50 billion by 2026 due to legalization efforts. Canadian companies like Aurora, Cronos, and Sundial are focusing on U.S. expansion.

Why It Matters

The cannabis industry's rapid growth and potential U.S. market access create opportunities for high returns. Legislative changes and Canadian companies' strategies enhance investment prospects.

Source: MarijuanaStocks
Market Sentiment: Positive
CRON stock latest news image
Quick Summary

Marijuana stock investors are optimistic for 2025, citing increased demand and rising profits among companies, despite volatility in trading. The sector shows potential for profitability.

Why It Matters

Rising demand and record profits in the cannabis sector suggest growth potential, attracting interest despite volatility, indicating possible investment opportunities for 2025.

Source: MarijuanaStocks
Market Sentiment: Neutral
CRON stock latest news image
Quick Summary

Cannabis stock investors face significant losses in 2023 but are hopeful for a recovery in 2025 as the U.S. legal marijuana market evolves.

Why It Matters

Cannabis stocks are underperforming, impacting investor sentiment. A potential recovery in 2025 could signal new opportunities and shifts in market dynamics for the sector.

Source: Market Watch
Market Sentiment: Negative
CRON stock latest news image
Quick Summary

The cannabis industry is evolving, with U.S. market projected to surpass $40 billion by 2025. Canadian stocks may benefit from federal reform and established infrastructure. Investors should track key stocks.

Why It Matters

Rapid evolution in the cannabis industry, especially in Canada, signals potential growth as U.S. market expansion and bipartisan support for legalization could drive stock performance.

Source: MarijuanaStocks
Market Sentiment: Positive

Frequently Asked Questions About CRON Stock

What is Cronos Group Inc's (CRON) stock forecast for 2025?

Based on our analysis of 8 Wall Street analysts, Cronos Group Inc (CRON) has a median price target of $2.05. The highest price target is $2.13 and the lowest is $1.97.

Is CRON stock a good investment in 2025?

According to current analyst ratings, CRON has 2 Buy ratings, 2 Hold ratings, and 1 Sell ratings. The stock is currently trading at $1.97. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for CRON stock?

Wall Street analysts predict CRON stock could reach $2.05 in the next 12 months. This represents a 4.1% increase from the current price of $1.97. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Cronos Group Inc's business model?

Cronos Group Inc. operates by cultivating, producing, and marketing a diverse range of cannabis products. The company generates revenue through the sale of its products, which include dried flower, pre-rolls, oils, vaporizers, edibles, and tinctures, marketed under well-known brands such as Spinach, Lord Jones, and PEACE NATURALS.

What is the highest forecasted price for CRON Cronos Group Inc?

The highest price target for CRON is $2.13 from at , which represents a 8.2% increase from the current price of $1.97.

What is the lowest forecasted price for CRON Cronos Group Inc?

The lowest price target for CRON is $1.97 from at , which represents a 0.0% increase from the current price of $1.97.

What is the overall CRON consensus from analysts for Cronos Group Inc?

The overall analyst consensus for CRON is neutral. Out of 8 Wall Street analysts, 2 rate it as Buy, 2 as Hold, and 1 as Sell, with a median price target of $2.05.

How accurate are CRON stock price projections?

Stock price projections, including those for Cronos Group Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.